Undercover Agents: Targeting Tumours with Modified Platelets (Q39441349)

12 September 2017

title

Undercover Agents: Targeting Tumours with Modified Platelets (English)

1 reference

12 September 2017

Stephanie R Hyslop

1 reference

12 September 2017

Emma C Josefsson

series ordinal

1 reference

12 September 2017

publication date

27 February 2017

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

235-246

1 reference

The platelet contribution to cancer progression

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Contribution of platelets to tumour metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Metastasis: new functional implications of platelets and megakaryocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Paraneoplastic thrombocytosis: the secrets of tumor self-promotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Paraneoplastic thrombocytosis in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Prognostic significance of thrombocytosis in patients with primary lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Antimetastatic effects associated with platelet reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

P-selectin deficiency attenuates tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Anticancer Platelet-Mimicking Nanovehicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Biomimetic particles as therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet activation by extracellular matrix proteins in haemostasis and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Mechanistic explanation for platelet contribution to cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet secretion: From haemostasis to wound healing and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Cytoskeleton of human platelets at rest and after spreading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet CLEC-2 and podoplanin in cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Metastasis: a question of life or death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Living in shear: platelets protect cancer cells from shear induced damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet aggregation in the formation of tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Role of tissue factor in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

The relationship between tissue factor and cancer progression: insights from bench and bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Prognosis of Cancers Associated with Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets induce apoptosis via membrane-bound FasL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet-induced inhibition of tumor cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets in inflammation and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets and the immune continuum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

New insights into the protective power of platelets in malaria infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets in defense against bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

PF4 Promotes Platelet Production and Lung Cancer Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Exhausted platelets in patients with malignant solid tumors without evidence of active consumption coagulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelets are not hyperreactive in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet phenotype changes associated with breast cancer and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Challenges in circulating tumour cell research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Detection of circulating tumor DNA in early- and late-stage human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Blood platelets contain tumor-derived RNA biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

A tour through the transcriptional landscape of platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Drug delivery and nanoparticles:applications and hazards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Strategies in biomimetic surface engineering of nanoparticles for biomedical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Nanoparticle-detained toxins for safe and effective vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Clearance of pathological antibodies using biomimetic nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Nanoparticle biointerfacing by platelet membrane cloaking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Ultrasoft microgels displaying emergent platelet-like behaviours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

Genetic engineering of platelets to neutralize circulating tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.01.006

10.1016/J.TRECAN.2017.01.006

7 January 2021

Identifiers

DOI

1 reference

release_xaqhig27cndxpcpzpv7aj5mmvm

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xaqhig27cndxpcpzpv7aj5mmvm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference